Maynard Ryan D Insider Trades

Insider Trading History

Track insider trading activity for Maynard Ryan D. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Foghorn Therapeutics
Foghorn Therapeutics FHTX
Chief Financial Officer
Holding Value $1.66M 400,000 shares
Last Trade
Feb 23, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.3M 400,000 shares
$5.75
$4.14
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $300k 67,546 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$151k 67,546 shares
$2.24
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $0 0 shares
Last Trade
Nov 12, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$485k 50,000 shares
$9.69
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $33.3k 7,500 shares
Last Trade
Nov 12, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$503k 50,000 shares
$10.06
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $255k 57,500 shares
Last Trade
Nov 12, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$485k 50,000 shares
$9.69
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $219k 49,303 shares
Last Trade
Jun 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$425k 49,303 shares
$8.62
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $222k 50,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$840k 50,000 shares
$16.79
$4.44
Cara Therapeutics
Cara Therapeutics CARA
CHIEF FINANCIAL OFFICER
Holding Value $71.8k 13,500 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$273k 13,500 shares
$20.19
$5.32
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $231k 51,955 shares
Last Trade
Jun 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$425k 51,955 shares
$8.18
$4.44
Cara Therapeutics
Cara Therapeutics CARA
Chief Financial Officer
Holding Value $431k 81,000 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.3M 81,000 shares
$362.16
$5.32
Cara Therapeutics
Cara Therapeutics CARA
CHIEF FINANCIAL OFFICER
Holding Value $42.6k 8,012 shares
Last Trade
Feb 08, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.31M 5,488 shares
$420.12
$5.32
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $227k 51,204 shares
Last Trade
Jun 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$425k 51,204 shares
$8.30
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $33.3k 7,500 shares
Last Trade
May 31, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$50.6k 7,500 shares
$6.75
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $155k 35,000 shares
Last Trade
Jun 29, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$922k 35,000 shares
$26.33
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $155k 35,000 shares
Last Trade
Jun 08, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.13M 35,000 shares
$32.17
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $155k 35,000 shares
Last Trade
Jun 10, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$698k 35,000 shares
$19.93
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $155k 35,000 shares
Last Trade
Jul 17, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$506k 35,000 shares
$14.45
$4.44
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & CFO
Holding Value $2.67M 75,000 shares
Last Trade
Nov 03, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.88M 100,000 shares
$38.80
$35.61
Rigel Pharmaceuticals
Rigel Pharmaceuticals RIGL
EVP & CFO
Holding Value $0 0 shares
Last Trade
Nov 03, 2017 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.88M 100,000 shares
$38.80
$35.61
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Director
Holding Value $155k 35,000 shares
Last Trade
Jun 01, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$191k 35,000 shares
$5.45
$4.44

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up